Literature DB >> 11112132

Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure.

M S Ip1, B Lam, L Y Chan, L Zheng, K W Tsang, P C Fung, W K Lam.   

Abstract

Epidemiological studies have implicated obstructive sleep apnea (OSA) as an independent comorbid factor in cardiovascular and cerebrovascular diseases. The recurrent episodes of occlusion of upper airways during sleep result in pathophysiological changes that may predispose to vascular diseases, and we postulate that nitric oxide may be one of the mediators involved. This study investigates the levels of circulating nitric oxide (NO), measured as serum nitrites and nitrates, in the early morning in OSA subjects compared with control subjects, and the effect of overnight nasal continuous positive airway pressure (nCPAP) in OSA subjects. Thirty men with moderate to severe OSA (age = 41.9 +/- 9.0; apnea-hypopnea index, AHI = 48.0 +/- 18.1) were compared with 40 healthy men (age = 40.6 +/- 5.4; AHI = 1.4 +/- 1.2). Serum nitrite/nitrate levels were significantly lower in OSA subjects (OSA = 38.9 +/- 22.9 microM, control subjects = 63.1 +/- 47.5 microM, p = 0.015). There was significant negative correlation between serum nitrites/nitrates and the following parameters: AHI (r = -0.389, p = 0.001), oxygen desaturation time (r = -0.346, p = 0.004), and systolic blood pressure (BP) (r = -0.335, p = 0.005). Stepwise multiple linear regression with systolic or diastolic BP as the dependent variable identified serum nitrites/nitrates as the only significant correlate. Twenty-two OSA subjects had measurements of serum NO at baseline and after an overnight application nCPAP. There was significant increase in serum NO after nCPAP (baseline = 30.5 +/- 14.4 microM, after nCPAP = 81.0 +/- 82.1 microM, p = 0.01). This study demonstrates, for the first time, that circulating NO is suppressed in OSA, and this is promptly reversible with the use of nCPAP. The findings offer support for nitric oxide being one of the mediators involved in the acute hemodynamic regulation and long-term vascular remodeling in OSA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112132     DOI: 10.1164/ajrccm.162.6.2002126

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  110 in total

1.  Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms.

Authors:  C M R Franco; A M J Lima; L Ataíde; O G Lins; C M M Castro; A A Bezerra; M F de Oliveira; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2012-03-09       Impact factor: 3.444

Review 2.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

3.  Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method.

Authors:  Madalina Macrea; Thomas Martin; Leon Zagrean; Zhenquan Jia; Hara Misra
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

Review 4.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

5.  Effects of nasal continuous positive airway pressure therapy on partners' sexual lives.

Authors:  Mustafa Acar; Coskun Kaya; Tolgahan Catli; Deniz Hancı; Ozge Bolluk; Yunus Aydin
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-10       Impact factor: 2.503

Review 6.  Exhaled breath analysis and sleep.

Authors:  Giovanna E Carpagnano
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

Review 7.  Pediatric sleep apnea: implications of the epidemic of childhood overweight.

Authors:  Carolyn E Ievers-Landis; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

8.  Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis).

Authors:  Colleen Glyde Julian; Enrique Vargas; Marcelino Gonzales; R Daniela Dávila; Anne Ladenburger; Lindsay Reardon; Caroline Schoo; Robert W Powers; Teofilo Lee-Chiong; Lorna G Moore
Journal:  Respir Physiol Neurobiol       Date:  2013-02-04       Impact factor: 1.931

Review 9.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

Review 10.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.